Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2004 | 09-2004 | 06-2004 | 03-2004 | 12-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 564 | 579 | 622 | 113 | 180 |
| Marketable Securities | N/A | N/A | N/A | 555 | 552 |
| TOTAL | $566 | $588 | $638 | $690 | $734 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $566 | $588 | $638 | $690 | $734 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4 | 61 | 67 | 62 | 79 |
| Accrued Expenses | 66 | N/A | N/A | N/A | N/A |
| TOTAL | $71 | $61 | $67 | $62 | $79 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $71 | $61 | $67 | $62 | $79 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29 | 29 | 29 | 29 | 29 |
| Retained earnings | -3,738 | -3,706 | -3,663 | -3,604 | -3,578 |
| Other shareholders' equity | 0 | 0 | 1 | 0 | 0 |
| TOTAL | $495 | $527 | $571 | $629 | $655 |
| Total Liabilities And Equity | $566 | $588 | $638 | $690 | $734 |